Physician profile
Kaleb Johnson
NPI 1518558691
$1,013.79
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $329 · 2023: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662 · Education: $22.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.25 |
| Education | $22.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $312.74 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $253.50 | 2023 | Xifaxan, Plenvu |
| Takeda Pharmaceuticals U.S.A., INC. | $159.61 | 2022-2023 | Entyvio |
| Regeneron Healthcare Solutions, INC. | $96.90 | 2022-2023 | Dupixent |
| Genzyme Corporation | $74.64 | 2023 | |
| Janssen Biotech, INC. | $60.12 | 2022 | |
| Eisai INC. | $24.95 | 2022 | |
| Ardelyx, INC. | $19.14 | 2023 | Ibsrela |
| Gilead Sciences, INC. | $12.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaleb Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.